Article History
Received: 25 May 2018
Accepted: 19 October 2018
First Online: 29 October 2018
Compliance with ethical standards
:
: The author(s) disclosed receipt of the following potential conflicts of interest. J. Sedgwick has received speaker’s honoraria from Shire and receives an educational grant towards PhD tuition fees and conference costs from the Royal College of Nursing (RCN) Foundation. P. Asherson has received funds for consultancy on behalf of KCL to Shire, Eli-Lilly, and Novartis, regarding the diagnosis and treatment of ADHD, and has received educational/research awards from Shire, Eli-Lilly, Novartis, Vifor Pharma, GW Pharma and QbTech and is a speaker at sponsored events for Shire, Eli-Lilly, and Novartis. All funds are used for studies of ADHD. The other author declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
: All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in this study.